title: The function of VEGF-A in lens development: formation of the hyaloid capillary network and protection against transient nuclear cataracts.
abstract: A network of capillaries branches from the hyaloid vascular system and surrounds the mammalian lens throughout much of its embryonic development. These vessels are presumed to be important for the growth and maturation of the lens, although the lenses of non-mammalian vertebrates have no comparable vessels. Over expression of VEGF-A in the lens increases the extent of these capillaries, but it is not known whether VEGF-A from the lens is necessary for their formation or survival. To address this question, we deleted Vegfa in the lens. This prevented the formation of the capillary networks adjacent to the lens capsule, but did not alter nearby hyaloid vessels at the surface of the retina. Postnatal lenses lacking Vegfa were smaller than wild type and, by 1 month of age, many had mild nuclear opacities. These opacities regressed with age. The lens is hypoxic throughout most of life and VEGF-A expression is often regulated by the transcription factor, hypoxia inducible factor-1. Lenses lacking Hif1a were of apparently normal size, had markedly reduced levels of mRNA for VEGF-A and glyceraldehyde-3-phosphate dehydrogenase, but had normal-appearing capillaries covering their surface. We conclude that VEGF-A from the lens is necessary for the formation of the normal hyaloid vascular system and that lack of these capillaries was the most likely cause of growth retardation during fetal and early postnatal lens development. In the absence of HIF-1 function, sufficient VEGF-A is produced by the lens to promote capillary formation. Further study is needed to explain the formation of the mild opacities seen in some lenses lacking Vegfa and their regression later in life.
authors.affiliation: Department of Ophthalmology and Visual Science, Washington University, St. Louis, MO 63110, USA.
authors.forename: Claudia M
authors.initials: CM
authors.lastname: Garcia
authors.forename: Ying-Bo
authors.initials: YB
authors.lastname: Shui
authors.forename: Meera
authors.initials: M
authors.lastname: Kamath
authors.forename: Justin
authors.initials: J
authors.lastname: DeVillar
authors.forename: Randall S
authors.initials: RS
authors.lastname: Johnson
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Gerber
authors.forename: Napoleone
authors.initials: N
authors.lastname: Ferrara
authors.forename: Michael L
authors.initials: ML
authors.lastname: Robinson
authors.forename: David C
authors.initials: DC
authors.lastname: Beebe
mesh_terms: D000375:Aging / Q000502:physiology; D000818:Animals; D002196:Capillaries / Q000378:metabolism; D002386:Cataract / Q000378:metabolism; D005260:Female; D018507:Gene Expression Regulation, Developmental; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D007907:Lens Nucleus, Crystalline / Q000196:embryology* / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D018919:Neovascularization, Physiologic; D011247:Pregnancy; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000502:physiology*
chemical_list: C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D042461:Vascular Endothelial Growth Factor A
references.citation: Anat Embryol (Berl). 1999 Oct;200(4):403-11
references.pmid: 10460477
references.citation: Science. 1977 Sep 2;197(4307):1010-2
references.pmid: 887936
references.citation: EMBO J. 1998 Jun 1;17(11):3005-15
references.pmid: 9606183
references.citation: Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3196-202
references.pmid: 15326140
references.citation: Development. 2007 Dec;134(24):4449-58
references.pmid: 18039971
references.citation: Transgenic Res. 2003 Aug;12(4):521-2
references.pmid: 12885173
references.citation: Am J Pathol. 2005 Nov;167(5):1451-9
references.pmid: 16251428
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3848-53
references.pmid: 11891301
references.citation: Dev Biol. 2005 Oct 1;286(1):270-86
references.pmid: 16126193
references.citation: Arch Ophthalmol. 2005 Jun;123(6):797-802
references.pmid: 15955981
references.citation: J Biol Chem. 1994 Sep 23;269(38):23757-63
references.pmid: 8089148
references.citation: Exp Eye Res. 2000 Jun;70(6):767-76
references.pmid: 10843781
references.citation: Dev Dyn. 1998 Nov;213(3):322-33
references.pmid: 9825867
references.citation: Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1930-9
references.pmid: 15161860
references.citation: Invest Ophthalmol. 1975 Jun;14(6):449-56
references.pmid: 1132941
references.citation: Development. 1994 Dec;120(12):3395-403
references.pmid: 7821211
references.citation: Proc Natl Acad Sci U S A. 1987 Jan;84(1):122-5
references.pmid: 3467344
references.citation: Development. 1999 Mar;126(6):1149-59
references.pmid: 10021335
references.citation: Mol Vis. 2007 Jan 19;13:47-56
references.pmid: 17277743
references.citation: Cell Death Differ. 1998 Feb;5(2):156-62
references.pmid: 10200460
references.citation: Angiogenesis. 2006;9(4):209-24
references.pmid: 17109192
references.citation: Nature. 1996 Apr 4;380(6573):439-42
references.pmid: 8602242
references.citation: Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2384-90
references.pmid: 15223821
references.citation: J Cell Biol. 1998 Nov 2;143(3):815-25
references.pmid: 9813099
references.citation: Development. 1999 Apr;126(7):1407-15
references.pmid: 10068634
references.citation: Invest Ophthalmol Vis Sci. 2003 Feb;44(2):839-47
references.pmid: 12556420
references.citation: Invest Ophthalmol Vis Sci. 1981 Nov;21(5):689-99
references.pmid: 7298273
references.citation: Invest Ophthalmol Vis Sci. 2004 Jan;45(1):7-14
references.pmid: 14691147
references.citation: Am J Physiol Cell Physiol. 2001 Jun;280(6):C1358-66
references.pmid: 11350730
references.citation: Genes Dev. 2000 Nov 1;14(21):2701-11
references.pmid: 11069887
references.citation: J Biol Chem. 2008 Apr 25;283(17):11435-44
references.pmid: 18305118
references.citation: Dev Biol. 2000 Jul 15;223(2):383-98
references.pmid: 10882523
references.citation: Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3911-9
references.pmid: 12939309